2 RCTs testing IV vs IO vascular access in OHCA patients just published in the @NEJM and concomitantly presented at #RESUS24@ERC_resus
➡️ No difference in 30d survival in both trials
➡️ Higher rate of ROSC with IV access in the #PARAMEDIC3 trial
🇬🇧 https://t.co/fXpWqcVfRT
🇩🇰 https://t.co/FFZYVTXkFl
Congratulations to the authors for randomizing 6082 + 1506 patients to answer this important question!
🚨 🏥 Please Retweet! Early enteral #nutrition (EN) w/in 3 d of ICU admit/intubation improves outcomes!
⬇️ Hospital MORTALITY
⬆️ D/C to Home
⬇️ ICU & Hosp LOS
⬇️ Vent Days
⬇️ Costs
🙋♂️Data from >27800 pts in real world practice
🔗 https://t.co/EdZuzRIg17
#ICUNutrition #FOAMcc
@drsh@drshahrul80@ICUnutrition
Hot Take on PROPHY-VAP trial:
🔥Prophylactic 2g ceftriaxone among patients intubated for airway protection reduced pneumonia & ICU/hospital length of stay
🔥Prophylaxis *reduced* total antibiotic exposure
🔥Consistent w/ SuDDICU & ANTHARTIC trials
Blog https://t.co/lXF1jMyj6a
The liver is awesome.
Yet its vocabulary is ... limited.
We can all tell when it is upset - high ALT, AST.
But that could mean anything!
So what's your specific patient's specific reason for high ALT?
True story
There have been 15 trials of tooth brushing in the ICU
and those trials have demonstrated fewer pneumonias and icu deaths
In @JAMAInternalMed
https://t.co/OisrG9d1Sj
Great #AHA23 so far: @AHA_Research
🥸8 Trials: 8 take aways below
Read the read👇👇
1/ATRESIA:
Patients with subclinical atrial fibrillation can benefit from apixaban to reduce the risk of stroke and systemic thromboembolism.
New IDSA/SCCM guidelines on evaluation of new fever in ICU!
🤒 bladder/esophageal > rectal > oral > axillary/ear
🤒CRP and/or procal rec for patients with low/intermediate risk of infection😳
🤒consider test for COVID, resp viruses
Fresh blogitorial: https://t.co/vgILWsi9E3
STRATUS Trial published @JAMA_current
🩸Cluster trial 25 ICUs >27,000 patients
🩸Switch to “small-volume” tubes that⬇️blood drawn for lab tests may⬇️RBC transfusion↔️effect on testing
🩸Available, cost-neutral, compatible with analyzers – will you switch?
https://t.co/sTkJVyfrgS
fresh blog: why the new brain death guidelines are unacceptable
🧠guidelines rec urine tox screen & time-based clearance of intoxicants, *ignoring* toxicology guidelines & toxicologists
🧠arbitrary ranges are required for labs (iCal must be 1 -1.3 mM😳)
https://t.co/BxZcupmRuD
OK here's a run down of why @CRYOSTAT_2 trial results will mark a turning point in the treatment of trauma-induced coagulopathy (TIC)
Paper in @JAMA_current: https://t.co/U9Yv0857JO
and some additional resources on our @CommsC4TS web pages: https://t.co/27fgr0DbfC
Firstly...
Thanks to @accpchest for the opportunity to present high risk #PE data from #FLAME 🔥 at #CHEST2023!
(Finally have a good reason to use that emoji!)
FT pts w significant decreased primary outcome and in-hospital mortality (1/3)
@RosovskyRachel@roblookstein
Very excited to have the voice and brains behind IBCC podcast and Crackcast, @adamdavidthomas co-instruct this year's Podcast CAMP Nov 30th, Dec 7th, Dec 14th. Plus keynote speaker @srrezaie of REBELCast
Details @ https://t.co/pVjmXYpdfs
in case you use an RSS feed:
the new IBCC chapters will be going up on a *separate* IBCC RSS feed. to subscribe, click the link shown below & copy the text that shows up into your RSS reader.
and if you've achieved this peak level of nerdiness, I honestly salute you 🫡